Caixin
Oct 29, 2021 08:00 AM

Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 7.9% in First Three Quarters of 2021

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 790.2 million yuan in the first three quarters of 2021, up 7.9% year-on-year.

Meanwhile, the company posted 2.8 billion yuan in revenue, up 6.9% year-on-year.

At the end of the reporting period, it had 11.6 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 13.8%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription